Xortx Therapeutics appoints Bumby as Chief Financial Officer

XORTX Therapeutics (XRTX) )XRTX) welcomes Dr. Michael Bumby as its Chief Financial Officer replacing James Fairbairn, the Company’s current Chief Financial Officer. Dr. Bumby, DVM, MBA, is currently a director and audit committee chair of MediPharm Labs (MEDIF) following their successful acquisition of VIVO Cannabis. where Dr. Bumby was CFO for six years.